Trademark: 79316976
Word
BYZOLPA
Status
Registered
Status Code
700
Status Date
Tuesday, January 18, 2022
Serial Number
79316976
Registration Number
6617409
Registration Date
Tuesday, January 18, 2022
Mark Type
4000
Filing Date
Wednesday, June 9, 2021
Published for Opposition
Tuesday, November 2, 2021

Trademark Owner History
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Jun 12, 2022
Notification Processed By Ib
May 16, 2022
Final Disposition Notice Sent To Ib
May 16, 2022
Final Disposition Processed
Feb 17, 2022
Grant Of Protection Created, To Be Sent To Ib
Jan 18, 2022
Registered-Principal Register
Dec 3, 2021
Changes/Corrections After Pub Approval Entered
Nov 23, 2021
Assigned To Petition Staff
Nov 10, 2021
Teas Post Publication Amendment Received
Nov 2, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 2, 2021
Published For Opposition
Oct 13, 2021
Notification Of Notice Of Publication E-Mailed
Sep 29, 2021
Approved For Pub - Principal Register
Sep 29, 2021
Assigned To Examiner
Sep 15, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 15, 2021
Teas Change Of Correspondence Received
Sep 15, 2021
Teas Change Of Domestic Representatives Address
Sep 15, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 15, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 15, 2021
Teas Change Of Owner Address Received
Aug 12, 2021
Application Filing Receipt Mailed
Aug 8, 2021
New Application Office Supplied Data Entered In Tram
Aug 7, 2021
Limitation From Original Application Entered
Aug 1, 2021
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24